Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Spitler

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Archives of Internal Medicine|February 1, 1976
Coexistent lymphoid interstitial pneumonia, pernicious anemia, and agammaglobulinemiaA I Levinson, P C Hopewell, D P Stites, et al.
Pediatrics|September 1, 1980
Nephropathy in the Wiskott-Aldrich syndromeL E Spitler, B B Wray, S Mogerman, et al.
Schweizerische Medizinische Wochenschrift|September 2, 1972
[Transfer factor. Immunologic basis and therapeutic experience]W H Hitzig, H P Fontanellaz, U Müntener, et al.
Molecular Biotherapy|September 1, 1990
The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in ratsJ B Stoudemire, R Mischak, C Foxall, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patientsS Harkonen, P Scannon, R P Mischak, et al.
JAMA|June 18, 1973
Myelopathy after duck embryo rabies vaccineH N Mozar, F B Finnigan, H Petzold, et al.
Cancer|February 1, 1975
Immunotherapy of melanoma with BCG: two fatalities following intralesional injectionC F McKhann, C G Hendrickson, L E Spitler, et al.
Molecular Biotherapy|June 1, 1990
Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MELR P Mischak, C Foxall, L L Rosendorf, et al.
Pediatrics|January 1, 1974
Treatment of mucocutaneous candidasis with transfer factorR D Feigin, P G Shackelford, S Eisen, et al.
Journal of Biological Response Modifiers|August 1, 1990
Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trialR Oratz, J L Speyer, J C Wernz, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Archives of Internal Medicine|February 1, 1976
Coexistent lymphoid interstitial pneumonia, pernicious anemia, and agammaglobulinemiaA I Levinson, P C Hopewell, D P Stites, et al.
Pediatrics|September 1, 1980
Nephropathy in the Wiskott-Aldrich syndromeL E Spitler, B B Wray, S Mogerman, et al.
Schweizerische Medizinische Wochenschrift|September 2, 1972
[Transfer factor. Immunologic basis and therapeutic experience]W H Hitzig, H P Fontanellaz, U Müntener, et al.
Molecular Biotherapy|September 1, 1990
The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in ratsJ B Stoudemire, R Mischak, C Foxall, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patientsS Harkonen, P Scannon, R P Mischak, et al.
JAMA|June 18, 1973
Myelopathy after duck embryo rabies vaccineH N Mozar, F B Finnigan, H Petzold, et al.
Cancer|February 1, 1975
Immunotherapy of melanoma with BCG: two fatalities following intralesional injectionC F McKhann, C G Hendrickson, L E Spitler, et al.
Molecular Biotherapy|June 1, 1990
Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MELR P Mischak, C Foxall, L L Rosendorf, et al.
Pediatrics|January 1, 1974
Treatment of mucocutaneous candidasis with transfer factorR D Feigin, P G Shackelford, S Eisen, et al.
Journal of Biological Response Modifiers|August 1, 1990
Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trialR Oratz, J L Speyer, J C Wernz, et al.
Pageof 9